🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/10/2018 67,83 68,65 67,56 68,53 +0,84% 1,60% 9.793.036
16/10/2018 66,65 68,04 66,56 67,96 +2,53% 2,23% 10.719.992
15/10/2018 66,02 66,99 65,77 66,28 -0,50% 1,85% 6.896.783
12/10/2018 65,55 66,85 65,29 66,61 +2,11% 2,39% 10.648.938
11/10/2018 67,15 67,30 64,71 65,24 -2,95% 3,85% 13.491.952
10/10/2018 69,16 69,55 67,17 67,22 -2,61% 3,45% 13.259.191
09/10/2018 68,19 69,33 67,72 69,03 +1,23% 2,36% 8.249.122
08/10/2018 67,68 68,42 67,64 68,19 +0,61% 1,14% 9.279.830
05/10/2018 67,97 68,41 67,35 67,78 -0,27% 1,56% 7.790.308
04/10/2018 67,86 68,09 67,23 67,96 -0,21% 1,27% 10.837.054
03/10/2018 68,79 69,10 68,08 68,10 -0,53% 1,48% 10.037.325
02/10/2018 68,67 68,86 67,83 68,46 +0,31% 1,50% 10.894.589
01/10/2018 67,81 68,60 67,38 68,25 +0,83% 1,80% 7.994.668
28/09/2018 67,48 67,94 67,41 67,69 +0,31% 0,78% 7.135.622
27/09/2018 67,11 67,92 66,87 67,48 +0,55% 1,56% 6.315.458
26/09/2018 67,68 67,89 66,97 67,11 -0,45% 1,37% 7.260.963
25/09/2018 67,61 68,11 67,29 67,41 -0,18% 1,21% 6.770.499
24/09/2018 67,67 68,03 67,40 67,54 -0,45% 0,94% 6.747.862
21/09/2018 67,66 68,30 67,66 67,84 +0,45% 0,94% 17.850.689
20/09/2018 67,13 67,59 66,84 67,54 +1,14% 1,11% 6.435.454
19/09/2018 66,94 67,34 66,45 66,77 -0,62% 1,33% 8.325.522
18/09/2018 67,19 67,65 66,70 67,19 +0,00% 1,42% 7.126.819
17/09/2018 66,65 67,23 66,46 67,19 +0,63% 1,16% 7.018.770
14/09/2018 67,50 67,50 66,47 66,77 -1,20% 1,53% 7.792.928
13/09/2018 66,95 67,69 66,39 67,59 +1,39% 1,94% 10.750.594
12/09/2018 66,22 66,81 65,95 66,66 +1,13% 1,30% 6.382.320
11/09/2018 66,60 66,60 65,91 65,92 -0,69% 1,05% 6.094.644
10/09/2018 66,79 67,36 66,35 66,37 -0,16% 1,51% 7.616.759
07/09/2018 65,99 66,58 65,70 66,48 +0,42% 1,34% 9.971.930
06/09/2018 65,81 66,36 65,67 66,20 +1,11% 1,04% 10.099.995